The US government‘s decision to not allow overseas pharmaceutical companies to import active pharmaceutical ingredient (API) applies to only one particular anti retroviral drug and is not a blanket ban, Biocon CMD Kiran Mazumdar-Shaw said.
first published: Feb 5, 2016 10:30 am
A collection of the most-viewed Moneycontrol videos.

Live: Will Nifty extend gains to third day and reclaim record highs? | Opening Bell

Decoding Small-Caps - Opportunities, Risks, and the Right Way to Invest

Live: Broad-based buying lifts D-Street for 2nd day, Nifty above 26,100 | Closing Bell

In your 20s? Quick hacks to turn your money mess into money moves
You are already a Moneycontrol Pro user.

